Arcadia Biosciences earnings were -$6.8M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest RKDA earnings report on Jun 30, 2024 announced Q2 2024 earnings of $1.1M, down 143.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, RKDA reported annual earnings of -$14.0M, with -9.1% growth. The next RKDA earnings date is Nov 12, 2024.
Arcadia Biosciences Earnings Reports & History FAQ
What were Arcadia Biosciences's earnings last quarter?
On RKDA's earnings call on Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q2 2024 earnings per share (EPS) of $0.78, up 27.87% year over year. Total RKDA earnings for the quarter were $1.06 million. In the same quarter last year, Arcadia Biosciences's earnings per share (EPS) was $0.61.
The next RKDA earnings call is Invalid Date. Add RKDA to your watchlist to be reminded of Arcadia Biosciences's next earnings date.
Is Arcadia Biosciences profitable or losing money?
As of the last Arcadia Biosciences earnings report, Arcadia Biosciences is currently losing money. Arcadia Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$6.78 million, a 56.73% decrease year over year.
What was RKDA's earnings growth in the past year?
As of Arcadia Biosciences's earnings date in Invalid Date, Arcadia Biosciences's earnings has grown year over year. RKDA earnings in the past year totalled -$6.78 million.
What are Arcadia Biosciences's earnings expectations?
The current EPS estimate for Arcadia Biosciences's earnings report in Invalid Date is -$0.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.